PACSIN2 Activators
The chemical class PACSIN2 Activators consists of compounds that can indirectly influence the activity of PACSIN2 through modulation of various cellular signaling pathways and cytoskeletal dynamics. Compounds like Phorbol Esters and Forskolin, which activate PKC and increase cAMP levels respectively, can modulate signaling pathways crucial for PACSIN2's functions in endocytosis and cytoskeletal regulation. Inhibitors of calmodulin and Rho kinase, such as W-7 and Y-27632, affect calcium signaling and cytoskeletal dynamics, potentially influencing PACSIN2's activity. Small GTPase inhibitors like ML141 and NSC23766, targeting Cdc42 and Rac1, are significant due to their roles in cytoskeletal organization, a key aspect of PACSIN2's function.
Furthermore, PI3K inhibitors, calcium channel blockers, and cAMP modulators such as LY294002, Nifedipine, and IBMX play roles in diverse signaling pathways that can impact PACSIN2 activity. Src kinase inhibitors like PP2 and compounds that affect cytoskeletal elements, including Nocodazole and Cytochalasin D, which destabilize microtubules and inhibit actin polymerization, also contribute to the indirect modulation of PACSIN2.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which can influence signaling pathways involving PACSIN2. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, potentially affecting pathways that modulate PACSIN2 activity. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Inhibits calmodulin, impacting calcium signaling pathways related to PACSIN2 activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits Rho kinase, affecting cytoskeletal dynamics and potentially influencing PACSIN2. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Cdc42 inhibitor, affecting cytoskeletal organization and potentially impacting PACSIN2. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Inhibits Rac1, a GTPase involved in cytoskeletal dynamics, potentially affecting PACSIN2. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Calcium channel blocker, potentially affecting calcium signaling and PACSIN2 activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Modulates cAMP levels, affecting signaling pathways related to PACSIN2. | ||||||